Fudan University Shanghai Cancer Center
Shanghai, China
NCT Number: NCT06102161
This is a clinical trial from the Eastern Cooperative Thoracic Oncology Project (ECTOP), numbered as ECTOP-1020. The goal of this clinical trial is to confirm the therapeutic effect of Wedge resection for ground-glass opacity-featured lung cancer with a size less than 2cm and a consolidation-to-tumor ratio between 0.25 to 0.5.
Trial opening soon.
Get Notified18 year–80 year
All sexes
Interventional
Phase 3
Shanghai, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Wedge resection is a surgical procedure that is done to remove a wedge-shaped section of lung tissue, usually for treating lung cancer. A wedge resection is less invasive than some of the other surgical options used to remove lung cancer.
Time frame: 5 years
The event is defined as the death due to any causes.
Time frame: 5 years
The event is defined as the tumor recurrence.
Time frame: 5 years
forced expiratory volume in one second (FEV1)
Time frame: 5 years
forced vital capacity (FVC)
Time frame: 5 years
Time frame: 5 years
Time frame: 5 years
Contact information is provided by the study sponsor or research team.
Fudan University
Other
Wedge Resection for Ground-glass Opacity-featured Lung Cancer With Size Less Than 2cm and Consolidation-to-tumor Ratio Between 0.25 to 0.5: a Single-arm, Multi-center, Prospective, Confirmatory Phase III Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07630168
Bronchial Neoplasms, Carcinoma
Chapel Hill, North Carolina, United States
View Trial DetailsNCT07720141
Lung Cancer, Lung Diseases
Houston, Texas, United States
View Trial DetailsNCT07625644
Bronchial Neoplasms, Carcinoma
View Trial DetailsNCT07700823
Lung Cancer, Lung Diseases
View Trial Details